The NeST (Neoadjuvant systemic therapy in breast cancer) study
I. Whitehead,
G. W. Irwin,
F. Bannon,
C. E. Coles,
E. Copson,
R. I. Cutress,
R. V. Dave,
M. D. Gardiner,
M. Grayson,
C. Holcombe,
S. Irshad,
C. O’Brien,
R. L. O’Connell,
C. Palmieri,
A. M. Shaaban,
N. Sharma,
J. K. Singh,
S. Potter,
S. A. McIntosh,
Liz Clayton,
Ellen Copson,
Karina Cox,
Tim Crook,
Beatrix Elsberger,
Ahmed Ghoneima,
Sirwan Hadad,
Anita Hargreaves,
Paul Healy,
Adam Heetun,
Dan Henderson,
Julia Henderson,
Natalie Hirst,
Fiona Hoar,
Mike Hughes,
Emma Iddles,
Sheeba Irshad,
Tracey Irvine,
Stacey Jones,
Sarantos Kaptanis,
Emma MacInnes,
Andrew McCanny,
Linda McLaughlin,
Anthony Neal,
Rachel O’Connell,
Neill Patani,
Belinda Pearce,
Mandana Pennick,
Simon Pilgrim,
Rene Roux,
Matthew Rowland,
Sunita Saha,
Kavita Sharma,
Jagdeep Singh,
Chiara Sirianni,
Brendan Skelly,
Rachel Soulsby,
Mark Tatterton,
Rob Thomas,
Medy Tsalic,
Raghavan Vidya,
Olivia Waker,
Lisa Whisker,
Ian Whitehead,
Janet Woods
Jan 22, 2021
Abstract: Background: Neoadjuvant systemic therapy (NST) is increasingly used in the treatment of breast cancer, yet it is clear that there is significant geographical variation in its use in the UK. This study aimed to examine...